Your search history is turned on.
Date: October 27, 2016 Jurisdictions: Alberta, British Columbia, Ontario
Number: BC1093941 CERTIFICATE OF AMALGAMATION BUSINESS CORPORATIONS ACT I Hereby Certify that CYNAPSUS THERAPEUTICS INC., incorporation number C1093896, and PROJECT PEGASUS SUB ACQUISITION ULC, incorporation number BC1091512, and SUNOVION CNS DEVELOPMENT CANADA ULC, incorporation number BC1087995 were amalgamated as one company under the name SUNOVION CNS DEVELOPMENT CANAD...
Date: October 24, 2016 Jurisdictions: Alberta, British Columbia, Ontario
Date: October 21, 2016 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - GOODMANS-#6618622-v1-Notice_of_Change_in_Corporate_Structure NOTICE OF CHANGE IN CORPORATE STRUCTURE PURSUANT TO SECTION 4.9 OF NATIONAL INSTRUMENT 51-102 Item 1: Names of the Parties to the Transaction Sunovion Pharmaceuticals Inc. (Sunovion), Sunovion CNS Development Canada ULC (the Purchaser) and Cynapsus Therapeutics Inc. (Cynapsus). ...
Microsoft Word - TOR01 -#6528638-v2-Pegasus - Material Change Report re Closing FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Cynapsus Therapeutics Inc. 828 Richmond Street West Toronto, Ontario M6J 1C9 (the Company) Item 2 Date of Material Change October 21, 2016 Item 3 News Release A news release was issued and dissemina...
www.sunovion.com Page 1 of 4 Sunovion Pharmaceuticals Inc. 84 Waterford Drive, Marlborough, MA 01752-7010 Tel 508-481-6700 N e w s R e l e a s e Sunovion Pharmaceuticals Completes Acquisition of Cynapsus Therapeutics Sunovion expands and diversifies its neurology portfolio...
Microsoft Word - GOODMANS-#6617862-v4-Early_Warning_Report_re__Closing.DOC 1 Form 62-103F1 Required Disclosure under the Early Warning Requirements State if this report is filed to amend information disclosed in an earlier report. Indicate the date of the report that is being amended. This report updated information contained in an Early Warning ...
Date: October 18, 2016 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - Cynapsus - Final Order and HSR Press Release _18Oct2016_ vF Cynapsus Therapeutics Obtains Final Court Order and HSR Arrangement TORONTO - October 18, 2016 Cynapsus Therapeutics Inc. ( CTH), a specialty central nervous system pharmaceutical company developing a fast use, sublingual thin film for the on with Parkinson...
Date: October 13, 2016 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - Cynapsus - Press Release Announcing Meeting Results _13Oct2016_ vF Cynapsus Therapeutics with Sunovion Pharmaceuticals TORONTO - October 13, 2016 Cynapsus Therapeutics Inc. ( CTH), a specialty central nervous system pharmaceutical use, sublingual thin film for the on with Parkinsons disease (PD), is pleased to an...
Microsoft Word - TOR01-#6536459-v1-Report_of_Voting_Results CYNAPSUS THERAPEUTICS INC. (the Company) REPORT OF VOTING RESULTS This report is filed pursuant to Section 11.3 of National Instrument 51-102 Continuous Disclosure Obligations and relates to the results of voting at the special meeting of the holders (the Securityholders) of the Companys common shar...
Date: September 28, 2016 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - Cynapsus -Press Release - ISS Recommendation _28Sep2016_ vF ISS RECOMMENDS CYNAPSUS THERAPEUTICS TORONTO September 28, 2016 (TSX: CTH) is pleased to announce today that independent proxy advisory firm, has recommended that (together, Securityholders) vote FOR the special resolution to approve the plan of arrangement (the Arran...